Clinical Trials Logo
  1. Home
  2. Vaccine Preventable Disease
  3. NCT04765839

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations — CERC  

Vaccine Preventable Disease Clinical Trial

Official title:
Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With Minority Populations

Clinical Trial Summary

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Clinical Trial Description

A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04765839
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date February 12, 2021
Completion date April 3, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04542330 - Using BCG to Protect Senior Citizens During the COVID-19 Pandemic Phase 3
Completed NCT04912661 - Iron and Vaccine Response N/A
Completed NCT04904744 - Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination N/A
Completed NCT05462249 - Impact of Catch-up HPV Vaccination
Recruiting NCT04899765 - Measles and BCG Vaccines for Mother and Child Phase 4
Active, not recruiting NCT04817917 - Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province Phase 4
Completed NCT04944134 - COVID-19 Antibody Levels After Vaccines
Recruiting NCT04954092 - Study of Gam-COVID-Vac in Adolescents Phase 2/Phase 3
Not yet recruiting NCT05140720 - Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age N/A
Active, not recruiting NCT04953130 - Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania Phase 4
Withdrawn NCT04818736 - COVID-19 Vaccine For Indirect Protection Phase 4